SCHEMBL24835774

SCHEMBL24835774

CCN[C@@H](C)c1ccc(C(=O)OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.49
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
CA12 O43570 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
CYP4A11 Q02928 1/20 0.47
LOXL2 Q9Y4K0 1/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP2D6 P10635 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HPGD P15428 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TSHR P16473 2/20 0.46
STAT3 P40763 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23207892 0.82 NR1H4 (0.51) MAPTSMN1; SMN2MEN1KMT2ATSHR
SCHEMBL25628053 0.81 LOXL2 (0.49) MAPTCYP4A11LOXL2CYP3A4CYP2C9
SCHEMBL12326116 0.80 CA1 (0.53) MAPTCA1CA2TDP1CA12
SCHEMBL29244668 0.80 CA1 (0.53) MAPTCA1CA2TDP1CA12
SCHEMBL27358541 0.80 CA1 (0.53) MAPTCA1CA2TDP1CA12
SCHEMBL24862002 0.80 ACACB (0.52) MAPTCA1CA2TDP1CA12
SCHEMBL28351919 0.79 MEN1 (0.49) MAPTCA1CA2TDP1CA12
SCHEMBL21147155 0.79 CA1 (0.52) MAPTCA1CA2TDP1CA12
SCHEMBL1791209 0.79 L3MBTL1 (0.52) MAPTCA1CA2TDP1CA12
SCHEMBL16684851 0.79 L3MBTL1 (0.52) MAPTCA1CA2TDP1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023278698-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2023-01-05 WO disclosed